Free tool
Stocks near their 52-week high
We cover 112 companies trading within 5% of their own 52-week high. The median market value in the group is $4.65B. Across the group, the median move over the past trading day is −0.08%. 100% of the 112 with a 200-day average trade above it. Price change over the past year runs from +19.7% to +248.2% across the middle 80 percent of the group, with a median of +64.2%. Across the group, 2 companies currently carry a tier A volume signal.
Other lists in this group
Table
112 of 3,992 companies match these filters.Clear filters
| Ticker | Company | Market cap (USD) | Size | 1Y return | Next report |
|---|---|---|---|---|---|
| JNJ | Johnson & Johnson | $658.24B | Mega cap | +55.40% | Oct 13, 2026 |
| ABBV | AbbVie Inc. | $469.68B | Mega cap | +29.36% | Oct 29, 2026 |
| MRK | Merck & Co., Inc. | $377.72B | Mega cap | +86.85% | Oct 29, 2026 |
| AMGN | Amgen Inc. | $238.06B | Mega cap | +56.24% | Nov 3, 2026 |
| TMO | Thermo Fisher Scientific Inc. | $234.31B | Mega cap | +30.17% | Oct 21, 2026 |
| PFE | Pfizer Inc. | $161.30B | Large cap | +18.72% | Nov 3, 2026 |
| VRTX | Vertex Pharmaceuticals Incorporated | $138.63B | Large cap | +40.66% | Nov 2, 2026 |
| BMY | Bristol-Myers Squibb Company | $138.03B | Large cap | +47.01% | Oct 29, 2026 |
| REGN | Regeneron Pharmaceuticals, Inc. | $83.89B | Large cap | +39.36% | Oct 28, 2026 |
| ARGX | argenx SE | $65.51B | Large cap | +47.90% | Oct 22, 2026 |
| TAK | Takeda Pharmaceutical Company Limited | $58.60B | Large cap | +22.68% | Oct 29, 2026 |
| BDX | Becton, Dickinson and Company | $51.81B | Large cap | +25.97% | Nov 5, 2026 |
| NTRA | Natera, Inc. | $48.53B | Large cap | +107.59% | Nov 5, 2026 |
| RVMD | Revolution Medicines, Inc. | $46.18B | Large cap | +466.35% | Nov 4, 2026 |
| TEVA | Teva Pharmaceutical Industries Limited | $44.19B | Large cap | +110.08% | Nov 4, 2026 |
| IQV | IQVIA Holdings Inc. | $43.04B | Large cap | +38.51% | Nov 3, 2026 |
| ONC | BeOne Medicines AG | $42.58B | Large cap | +25.21% | Nov 5, 2026 |
| WAT | Waters Corporation | $40.67B | Large cap | +40.57% | Oct 30, 2026 |
| RPRX | Royalty Pharma plc | $35.71B | Large cap | +74.00% | Nov 4, 2026 |
| ILMN | Illumina, Inc. | $33.95B | Large cap | +125.88% | Oct 29, 2026 |
| DXCM | DexCom, Inc. | $33.65B | Large cap | +16.47% | Oct 29, 2026 |
| BIIB | Biogen Inc. | $32.66B | Large cap | +62.12% | Oct 29, 2026 |
| LH | Labcorp Holdings Inc. | $27.39B | Large cap | +21.14% | Nov 3, 2026 |
| DGX | Quest Diagnostics Incorporated | $26.99B | Large cap | +38.12% | Oct 20, 2026 |
| ROIV | Roivant Sciences Ltd. | $26.55B | Large cap | +206.51% | Nov 9, 2026 |
| INCY | Incyte Corporation | $25.97B | Large cap | +51.01% | Oct 27, 2026 |
| GH | Guardant Health, Inc. | $22.94B | Large cap | +169.17% | Oct 28, 2026 |
| THC | Tenet Healthcare Corporation | $21.89B | Large cap | +50.70% | Oct 27, 2026 |
| GMAB | Genmab A/S | $21.42B | Large cap | +36.20% | Nov 5, 2026 |
| SOLV | Solventum Corporation | $15.58B | Large cap | +25.57% | Nov 5, 2026 |
| CRL | Charles River Laboratories International, Inc. | $14.09B | Large cap | +81.27% | Nov 4, 2026 |
| EXEL | Exelixis, Inc. | $14.05B | Large cap | +45.68% | Oct 27, 2026 |
| RVTY | Revvity, Inc. | $13.93B | Large cap | +42.93% | Oct 26, 2026 |
| HALO | Halozyme Therapeutics, Inc. | $12.41B | Large cap | +46.30% | Nov 2, 2026 |
| TECH | Bio-Techne Corporation | $11.35B | Large cap | +29.33% | Nov 9, 2026 |
| PRAX | Praxis Precision Medicines, Inc. | $10.54B | Large cap | +704.28% | Nov 9, 2026 |
| KYMR | Kymera Therapeutics, Inc. | $10.53B | Large cap | +197.09% | Nov 3, 2026 |
| BIO | Bio-Rad Laboratories, Inc. | $10.40B | Large cap | +32.71% | Oct 29, 2026 |
| HSIC | Henry Schein, Inc. | $10.30B | Large cap | +31.02% | Nov 3, 2026 |
| RGEN | Repligen Corporation | $10.25B | Large cap | +51.67% | Nov 3, 2026 |
| APGE | Apogee Therapeutics, Inc. | $10.21B | Large cap | +257.11% | Nov 9, 2026 |
| TWST | Twist Bioscience Corporation | $9.41B | Mid cap | +451.89% | Nov 16, 2026 |
| IMVT | Immunovant, Inc. | $9.07B | Mid cap | +189.13% | Nov 9, 2026 |
| CRNX | Crinetics Pharmaceuticals, Inc. | $9.00B | Mid cap | +179.08% | Nov 5, 2026 |
| TXG | 10x Genomics, Inc. | $8.37B | Mid cap | +358.35% | Nov 5, 2026 |
| SRRK | Scholar Rock Holding Corporation | $7.31B | Mid cap | +74.18% | Nov 12, 2026 |
| HNGE | Hinge Health, Inc. | $7.25B | Mid cap | +56.66% | Nov 3, 2026 |
| CHE | Chemed Corporation | $7.11B | Mid cap | +20.79% | Oct 27, 2026 |
| CGON | CG Oncology, Inc. | $6.95B | Mid cap | +196.15% | Nov 9, 2026 |
| TVTX | Travere Therapeutics, Inc. | $6.24B | Mid cap | +284.86% | Oct 29, 2026 |
| TFX | Teleflex Incorporated | $5.88B | Mid cap | +8.06% | Oct 29, 2026 |
| SHC | Sotera Health Company | $5.58B | Mid cap | +18.42% | Nov 3, 2026 |
| MMSI | Merit Medical Systems, Inc. | $5.44B | Mid cap | −0.28% | Oct 29, 2026 |
| ACAD | ACADIA Pharmaceuticals Inc. | $5.07B | Mid cap | +11.33% | Nov 4, 2026 |
| DYN | Dyne Therapeutics, Inc. | $4.92B | Mid cap | +93.26% | Nov 5, 2026 |
| HAE | Haemonetics Corporation | $4.85B | Mid cap | +93.71% | Nov 5, 2026 |
| ELVN | Enliven Therapeutics, Inc. | $4.46B | Mid cap | +194.32% | Nov 11, 2026 |
| CON | Concentra Group Holdings Parent, Inc. | $4.44B | Mid cap | +50.93% | Nov 5, 2026 |
| HTFL | Heartflow, Inc. | $4.26B | Mid cap | +40.79% | Nov 11, 2026 |
| ITGR | Integer Holdings Corporation | $4.25B | Mid cap | +15.84% | Oct 29, 2026 |
| ADPT | Adaptive Biotechnologies Corporation | $4.18B | Mid cap | +101.70% | Nov 4, 2026 |
| IDYA | IDEAYA Biosciences, Inc. | $4.01B | Mid cap | +66.32% | Nov 9, 2026 |
| ABCL | AbCellera Biologics Inc. | $3.97B | Mid cap | +181.38% | Nov 5, 2026 |
| RCUS | Arcus Biosciences, Inc. | $3.92B | Mid cap | +191.29% | Oct 27, 2026 |
| OGN | Organon & Co. | $3.62B | Mid cap | +50.67% | Nov 9, 2026 |
| IMNM | Immunome, Inc. | $3.34B | Mid cap | +188.94% | Nov 5, 2026 |
| AVAH | Aveanna Healthcare Holdings Inc. | $2.97B | Mid cap | +73.50% | Nov 5, 2026 |
| ATAI | AtaiBeckley Inc. | $2.74B | Mid cap | +61.71% | Nov 12, 2026 |
| AXGN | AxoGen, Inc. Common Stock | $2.68B | Mid cap | +219.58% | Oct 28, 2026 |
| PGEN | Precigen, Inc. | $2.65B | Mid cap | +61.66% | Nov 12, 2026 |
| CDNA | CareDx, Inc. | $2.64B | Mid cap | +283.45% | Nov 3, 2026 |
| PHVS | Pharvaris N.V. | $2.60B | Mid cap | +55.59% | Nov 12, 2026 |
| RAPP | Rapport Therapeutics, Inc. | $2.52B | Mid cap | +250.70% | Nov 5, 2026 |
| ATRC | AtriCure, Inc. | $2.45B | Mid cap | +29.14% | Oct 27, 2026 |
| HRMY | Harmony Biosciences Holdings, Inc. | $2.31B | Mid cap | +4.23% | Nov 3, 2026 |
| NEO | NeoGenomics, Inc. | $2.26B | Mid cap | +145.34% | Oct 27, 2026 |
| ADUS | Addus HomeCare Corporation | $2.25B | Mid cap | +4.50% | Nov 2, 2026 |
| PVLA | Palvella Therapeutics, Inc. | $2.22B | Mid cap | +173.39% | Nov 11, 2026 |
| MD | Pediatrix Medical Group, Inc. | $2.19B | Mid cap | +56.87% | Nov 2, 2026 |
| ZYME | Zymeworks Inc. | $2.10B | Mid cap | +96.28% | Nov 5, 2026 |
| VIR | Vir Biotechnology, Inc. | $1.87B | Small cap | +111.85% | Nov 4, 2026 |
| BLFS | BioLife Solutions, Inc. | $1.82B | Small cap | +45.50% | Nov 5, 2026 |
| FBRX | Forte Biosciences, Inc. | $1.63B | Small cap | +589.87% | Nov 9, 2026 |
| LBRX | LB Pharmaceuticals Inc | $1.55B | Small cap | +178.41% | Nov 12, 2026 |
| REPL | Replimune Group, Inc. | $1.50B | Small cap | +187.16% | Nov 5, 2026 |
| CGEM | Cullinan Therapeutics, Inc. | $1.48B | Small cap | +188.15% | Nov 5, 2026 |
| ANRO | Alto Neuroscience, Inc. | $1.43B | Small cap | +786.65% | Nov 11, 2026 |
| MGTX | MeiraGTx Holdings plc | $1.43B | Small cap | +100.54% | Nov 12, 2026 |
| DRTS | Alpha Tau Medical Ltd. | $1.38B | Small cap | +343.92% | Nov 19, 2026 |
| NUTX | Nutex Health Inc. | $1.34B | Small cap | +118.22% | Nov 5, 2026 |
| CRON | Cronos Group Inc. | $1.31B | Small cap | +38.67% | Nov 5, 2026 |
| ABUS | Arbutus Biopharma Corporation | $1.03B | Small cap | +42.19% | Nov 16, 2026 |
| CADL | Candel Therapeutics, Inc. | $1.02B | Small cap | +124.70% | Nov 12, 2026 |
| TALK | Talkspace, Inc. | $870.57M | Small cap | +93.73% | Oct 29, 2026 |
| ACHV | Achieve Life Sciences, Inc. | $851.00M | Small cap | +177.52% | Nov 5, 2026 |
| VREX | Varex Imaging Corporation | $778.90M | Small cap | +61.40% | Nov 17, 2026 |
| SOPH | SOPHiA GENETICS SA | $726.14M | Small cap | +156.16% | Nov 3, 2026 |
| OABI | OmniAb, Inc. | $699.33M | Small cap | +198.76% | Nov 4, 2026 |
| SGMT | Sagimet Biosciences Inc. | $675.04M | Small cap | +39.59% | Nov 12, 2026 |
| ANGO | AngioDynamics, Inc. | $648.51M | Small cap | +56.74% | Oct 1, 2026 |
| CTNM | Contineum Therapeutics, Inc. | $640.31M | Small cap | +70.03% | Oct 29, 2026 |
| EOLS | Evolus, Inc. | $579.92M | Small cap | +15.83% | Nov 4, 2026 |
| PRLD | Prelude Therapeutics Incorporated | $522.47M | Small cap | +412.50% | Nov 11, 2026 |
| PBYI | Puma Biotechnology, Inc. | $472.84M | Small cap | +79.61% | Nov 5, 2026 |
| IKT | Inhibikase Therapeutics, Inc. | $347.44M | Small cap | +39.11% | Nov 13, 2026 |
| RCEL | AVITA Medical, Inc. | $327.52M | Small cap | +133.77% | Nov 5, 2026 |
| SMTI | Sanara MedTech Inc. | $318.55M | Small cap | +2.09% | Nov 11, 2026 |
| BDSX | Biodesix, Inc. | $296.22M | Small cap | +225.53% | Nov 3, 2026 |
| ORMP | Oramed Pharmaceuticals Inc. | $218.55M | Small cap | +159.19% | Nov 12, 2026 |
| CPIX | Cumberland Pharmaceuticals Inc. | $130.35M | Small cap | +163.82% | Nov 3, 2026 |
| INMB | INmune Bio Inc. | $67.86M | Micro cap | +19.56% | Oct 29, 2026 |
| BFRI | Biofrontera Inc. | $22.72M | Micro cap | +77.91% | Nov 11, 2026 |
Covers ~22,000 companies across the US, Europe and Asia-Pacific (ex mainland China, Hong Kong and India), refreshed nightly. Every listed stock opens as a full analysis for $9.90.